Dromoran

• Narcotics
• Analgesics, Opioid

• Antalgin
• Aromarone
• Cetarin
• Dea No. 9220
• Dea No. 9733
• Dromoran
• Lemoran
• Levo-Dromoran
• Levorfanol [Inn-Spanish]
• Levorfanolo [Dcit]
• Levorphan
• Levorphanal
• Levorphanol Dl-Form
• Levorphanol Tartrate
• Levorphanolum [Inn-Latin]
• Methorfinan [Czech]
• Methorphinan
• Orphan
• Racemethorphanum
• Racemic Dromoran
• Racemorfano [Inn-Spanish]
• Racemorphan
• Racemorphan [Ban:Inn]
• Racemorphane [Inn-French]
• Racemorphanum [Inn-Latin]

• No information avaliable

C₁₇H₂₃NO

http://www.rxlist.com/cgi/generic2/levorphanol.htm

Dromoran MSDS

Woods LA, et al. J Pharmacol Exp Ther. 1958 Sep;124(1):1-8.

257.371 g/mol

198-199 ^oC

1840 mg/L

Solid

3.986

Tablet

For the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate

Levorphanol is a potent synthetic opioid analgesic indicated for the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate. Levorphanol is similar to morphine in its actions, however it is up to 8 times more potent than morphine. Levorphanol produces a degree of respiratory depression similar to that produced by morphine at equianalgesic doses, and like many mu-opioid drugs, levorphanol produces euphoria or has a positive effect on mood in many individuals.

Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.

LD₅₀=150 mg/kg (orally in rats). Signs of overdose include nausea, emesis, dizziness, respiratory depression, hypotension, urinary retention, cardiac arrhythmias, allergic reactions, skin rash, and uticaria.

No information avaliable

Humans and other mammals